comparemela.com

Latest Breaking News On - Leber amaurosis - Page 1 : comparemela.com

VARIANT Receives European Orphan Drug Designation for its Gene Therapy Product Candidate, VAR002, for the Treatment of Both Leber Congenital Amaurosis and Cone-Rod dystrophy

Variant, a company dedicated to developing innovative treatments for inherited eye orphan diseases, announces the decision of the European Commission to grant Orphan Drug Designation (ODD) for VAR002

Kostenloser wertpapierhandelFlorence portejoieCommittee for orphan medicinal productsEuropean commissionEuropean medicine agencyOrphan drug designationOrphan medicinal productsLeber amaurosis

vimarsana © 2020. All Rights Reserved.